Redemption of ANZ Capital Notes 4

Australia and New Zealand Banking Group Limited
9/833 Collins Street Docklands Victoria 3008 Australia
ABN 11 005 357 522
News Release
For release: 14 February 2024

Redemption of outstanding ANZ Capital Notes 4

In connection with the ANZ Capital Notes 9 offer launched by Australia and New Zealand
Banking Group Limited (ANZBGL) today (Offer), ANZBGL today announced it will redeem
all outstanding ANZ Capital Notes 4 issued by ANZBGL on 27 September 2016 (ASX:
AN3PG) (CN4) for their Face Value of $100 each on 20 March 2024 and accordingly has
issued the attached Exchange Notice in respect of those CN4.

The CN4 were issued on the terms set out in Appendix A to the CN4 prospectus dated 24
August 2016 (as most recently amended on 3 January 2023) (CN4 Terms).

The last day of trading of the CN4 on the ASX will be 6 March 2024.

CN4 Holders on the Register on 8 March 2024 will be entitled to the Face Value of $100 per
CN4 and, subject to the conditions set out in the CN4 Terms, will also receive a final
Distribution of $1.8227 per CN4.

Unless otherwise defined, capitalised terms in this release have the meaning given to them
in the CN4 Terms.

For investor enquiries about the ANZ Capital Notes 9 Offer, including the
Reinvestment Offer, or the CN4 redemption, please visit capitalnotes.anz.com or
call the ANZ Information Line on 1800 113 399 (within Australia) or +61 3 9415
4010 (international) (Monday to Friday – 8:30am to 5:30pm Melbourne time).

For media enquiries only contact:
Lachlan McNaughton, Senior Manager Media Relations +61 457 494 414


Approved for distribution by ANZ Group’s Continuous Disclosure Committee

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR
INTO THE UNITED STATES OF AMERICA. This statement does not constitute an offer
of any securities for sale. The securities referenced will not be registered under the
U.S. Securities Act of 1933, as amended (Securities Act), or the securities laws of
any state or jurisdiction of the United States and may not be offered, sold or resold,
directly or indirectly, in the United States or to, or for the account or benefit of, any
U.S. person (as defined in Regulation S under the Securities Act), except pursuant
to an exemption from, or in a transaction not subject to, the Securities Act.